Drug intelligence / Profile preview

Glucovital

Development stage: Unknown
Lead developer: S.P. Pharmaceuticals
Administration: Oral

Overview

**Glucovital** is an oral Ayurvedic multi-herb capsule marketed by S.P. Pharmaceuticals for blood-sugar support and diabetes management. The manufacturer lists karela, jamun, methi, neem, amla, and giloy as ingredients, and also describes bitter gourd, gymnema, and jamun as supporting insulin production and blood-glucose regulation. It is a retail herbal product rather than a clinically developed pharmaceutical asset; no specific molecular target, standardized active constituent, or clinical development program was identified.

Brand names: Glucovital
Other names: Glucovita

Beyond the preview

Go deeper on Glucovital.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glucovital.

Explore the full profile